Why the study?
Does intravenous recombinant human superoxide dismutase (h-SOD) improve recovery of left ventricular function in patients undergoing PTCA for acute myocardial infarction?
Does intravenous recombinant human superoxide dismutase (h-SOD) improve recovery of left ventricular function in patients undergoing PTCA for acute myocardial infarction?
Intravenous administration of the free radical scavenger h-SOD before PTCA in acute myocardial infarction does not provide additional benefit for left ventricular function recovery.
No takes yet. Share an insight, caveat, or question.
No benefit from h-SOD on LV recovery after PTCA for AMI; challenges free-radical scavenging as adjunctive reperfusion therapy.
Flaherty et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: